United States securities and exchange commission logo

                           June 2, 2021

       Chris Chang Yu
       Chief Executive Officer
       AnPac Bio-Medical Science Co., Ltd.
       Suite 127, 2260 Clove Drive
       San Jose, CA 95128

                                                        Re: AnPac Bio-Medical
Science Co., Ltd.
Statement on Form F-3
                                                            Filed May 28, 2021
                                                            File No. 333-256630

       Dear Dr. Yu:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Jason L.
Drory at 202-551-8342 with any questions.


                           Division of Corporation Finance

                           Office of Life Sciences
       cc:                                              William S. Rosenstadt,